Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma -2

Clinical trial NCT04898712 · UNKNOWN

Trial details

NCT number: NCT04898712
Sponsor: Unity Health Toronto
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Subdural Hematoma

Start date: 2021-07-01
Primary completion: 2023-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.